Patents by Inventor Hans Albertsen

Hans Albertsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF USING GENETIC MARKERS ASSOCIATED WITH ENDOMETRIOSIS
    Publication number: 20210292841
    Abstract: Disclosed herein are methods of using genetic markers associated with endometriosis, for example via a computer-implemented program to predict risk of developing endometriosis, and methods of preventing or treating endometriosis or a symptom thereof.
    Type: Application
    Filed: September 6, 2019
    Publication date: September 23, 2021
    Inventors: Hans ALBERTSEN, Rakesh N. CHETTIER, Kenneth WARD, VeeAnn ARGYLE
  • GENETIC MARKERS ASSOCIATED WITH ENDOMETRIOSIS AND USE THEREOF
    Publication number: 20200087728
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: February 27, 2019
    Publication date: March 19, 2020
    Inventors: Kenneth WARD, Hans ALBERTSEN, Georges C. FRECH, Rakesh N. CHETTIER
  • METHODS OF USING GENETIC MARKERS ASSOCIATED WITH ENDOMETRIOSIS
    Publication number: 20200063202
    Abstract: Disclosed herein are methods of using genetic markers associated with endometriosis, for example via a computer-implemented program to predict risk of developing endometriosis, and methods of preventing or treating endometriosis or a symptom thereof. For example, the present disclosure provides a method of testing for endometriosis and treating a subject having at least one genetic mutation in at least one gene of UGT2B28, USP17L2 (alias DUBS), and METTL11B such that the subject is prevented from developing endometriosis or such that endometriosis in the subject is prevented from progressing. The treatment may be a surgical intervention, a hormone treatment, a pharmaceutical treating, or a combination thereof.
    Type: Application
    Filed: April 25, 2019
    Publication date: February 27, 2020
    Inventors: Hans ALBERTSEN, Rakesh N. CHETTIER, Kenneth WARD
  • Method of Testing for Endometriosis and Treatment Therefor
    Publication number: 20180245156
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: December 11, 2017
    Publication date: August 30, 2018
    Applicant: Juneau Biosciences, LLC
    Inventors: Kenneth Ward, Rakesh N. Chettier, Hans Albertsen
  • Method of testing for endometriosis and treatment therefor
    Patent number: 9840738
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Grant
    Filed: January 12, 2015
    Date of Patent: December 12, 2017
    Inventors: Kenneth Ward, Rakesh N. Chettier, Hans Albertsen
  • Method of testing for endometriosis and treatment therefor
    Patent number: 9434991
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: September 6, 2016
    Assignee: Juneau Biosciences, LLC.
    Inventors: Kenneth Ward, Rakesh N. Chettier, Hans Albertsen
  • Method of Testing for Endometriosis and Treatment Therefor
    Publication number: 20150368714
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: March 7, 2013
    Publication date: December 24, 2015
    Applicant: JUNEAU BIOSCIENCES, LLC
    Inventors: Kenneth Ward, Rakesh N. Chettier, Hans Albertsen
  • Method of Determining Predisposition to Endometriosis
    Publication number: 20150363558
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: September 4, 2012
    Publication date: December 17, 2015
    Applicant: JUNEAU BIOSCIENCES, LLC
    Inventors: Kenneth Ward, Pamela Farrington, Rakesh N. Chettier, Hans Albertsen
  • Method of Testing for Endometriosis and Treatment Therefor
    Publication number: 20150133382
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: January 12, 2015
    Publication date: May 14, 2015
    Applicant: JUNEAU BIOSCIENCES, LLC
    Inventors: Kenneth Ward, Rakesh N. Chettier, Hans Albertsen
  • Method of testing for endometriosis and treatment therefor
    Patent number: 8932993
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Grant
    Filed: March 7, 2013
    Date of Patent: January 13, 2015
    Assignee: Juneau Biosciences, LLC.
    Inventors: Kenneth Ward, Rakesh N. Chettier, Hans Albertsen
  • Genetic Markers Associated with Endometriosis and Use Thereof
    Publication number: 20100272713
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis and the use of such risk information in selectively administering a treatment that at least partially prevents or compensates for an endometriosis related symptom.
    Type: Application
    Filed: April 22, 2010
    Publication date: October 28, 2010
    Applicant: JUNEAU BIOSCIENCES, LLC
    Inventors: Kenneth Ward, Hans Albertsen
  • Genetic Markers Associated with Endometriosis and Use Thereof
    Publication number: 20080305967
    Abstract: The present invention relates to novel genetic markers associated with endometriosis and risk of developing endometriosis, and methods and materials for determining whether a human subject has endometriosis or is at risk of developing endometriosis.
    Type: Application
    Filed: March 27, 2008
    Publication date: December 11, 2008
    Applicant: JUNEAU BIOSCIENCES, LLC
    Inventors: Kenneth Ward, Hans Albertsen
  • Diagnosis for mutant APC by immunoassay
    Patent number: 6413727
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: July 2, 2002
    Assignees: The Johns Hopkins University, University of Utah, Japanese Foundation for Cancer Research Cancer Institute, Zeneca Limited
    Inventors: Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Kenneth Kinzler, Alexander Fred Markham, Yusuke Nakamura, Andrew Thliveris, Bert Vogelstein, Raymond L. White
  • Detection of APC proteins
    Patent number: 6114124
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: September 5, 2000
    Assignees: The Johns Hopkins University, University of Utah, The Cancer Institute, Imperial Chemical Industries PLC
    Inventors: Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Kenneth Kinzler, Alexander Fred Markham, Yusuke Nakamura, Andrew Thliveris, Bert Vogelstein, Raymond L. White
  • APC (adenomatous polyosis coli) protein
    Patent number: 5783666
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: July 21, 1998
    Assignees: The Johns Hopkins University, The University of Utah, Zeneca Pharmaceuticals, The Cancer Institute
    Inventors: Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Kenneth Kinzler, Alexander Fred Markham, Yusuke Nakamura, Andrew Thliveris, Bert Vogelstein, Raymond L. White
  • APC antibodies
    Patent number: 5691454
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: November 25, 1997
    Assignees: The Johns Hopkins University, University of Utah, the Cancer Institute, Imperial Chemical Industries PLC
    Inventors: Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Kenneth Kinzler, Alexander Fred Markham, Yusuke Nakamura, Andrew Thliveris, Bert Vogelstein, Raymond L. White
  • Detection of inherited and somatic mutations of APC gene in colorectal cancer of humans
    Patent number: 5648212
    Abstract: Methods are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. APC is a tumor suppressor.
    Type: Grant
    Filed: August 12, 1994
    Date of Patent: July 15, 1997
    Assignees: The John Hopkins University, University of Utah, Japanese Foundation for Cancer Research Cancer Institute, Zeneca Limited
    Inventors: Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Kenneth Kinzler, Alexander Markham, Yusuke Nakamura, Andrew Thliveris, Bert Vogelstein, Raymond L. White
  • APC gene and nucleic acid probes derived therefrom
    Patent number: 5352775
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: August 8, 1991
    Date of Patent: October 4, 1994
    Assignees: The Johns Hopkins Univ., The Univ. of Utah, Imperial Chemical Industries, Cancer Institute
    Inventors: Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip J. Hedge, Geoff Joslyn, Kenneth Kinzler, Alexander F. Markham, Yusuke Nakamura, Andrew Thliveris, Bert Vogelstein, Raymond L. White
  • APC Antibodies
    Patent number: RE38916
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: November 18, 1999
    Date of Patent: December 6, 2005
    Assignees: The Johns Hopkins University, The University of Utah, The Cancer Institute, Zeneca Limited
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip John Hedge, Geoff Joslyn, Alexander Fred Markham, Yusuka Nakamura, Andrew Thilveris, Raymond L. White
  • APC antibodies
    Patent number: RE40948
    Abstract: A human gene termed APC is disclosed. Methods and kits are provided for assessing mutations of the APC gene in human tissues and body samples. APC mutations are found in familial adenomatous polyposis patients as well as in sporadic colorectal cancer patients. APC is expressed in most normal tissues. These results suggest that APC is a tumor suppressor.
    Type: Grant
    Filed: October 24, 2001
    Date of Patent: October 27, 2009
    Assignees: The Johns Hopkins University, Astrazeneca United Kingdom, Ltd., Cancer Institute, Japanese, Foundation for Cancer Research, The University of Utah
    Inventors: Bert Vogelstein, Kenneth W. Kinzler, Hans Albertsen, Rakesh Anand, Mary Carlson, Joanna Groden, Philip Hedge, Geoff Joslyn, Alexander Fred Markham, Yusuke Nakumura, Andrew Thliveris, Raymond White